Avricore Health (TSE:AVCR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Avricore Health Inc. reported a significant rise in revenues and profitability for the third quarter of 2024, with a 58% year-over-year revenue increase. The company is strategically expanding its HealthTab™ services in the UK, capitalizing on the region’s strong investment in pharmacy-led healthcare services.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
